Vivos Therapeutics Future Growth
Future criteria checks 2/6
Vivos Therapeutics is forecast to grow earnings and revenue by 40.1% and 29.7% per annum respectively while EPS is expected to grow by 79% per annum.
Key information
40.1%
Earnings growth rate
79.0%
EPS growth rate
| Healthcare earnings growth | 19.4% |
| Revenue growth rate | 29.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 20 Aug 2024 |
Recent future growth updates
Recent updates
Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Leap 41% Yet They're Still Not Telling The Full Story
Sep 10
It's Down 44% But Vivos Therapeutics, Inc. (NASDAQ:VVOS) Could Be Riskier Than It Looks
Apr 25It's Down 48% But Vivos Therapeutics, Inc. (NASDAQ:VVOS) Could Be Riskier Than It Looks
Feb 02Fewer Investors Than Expected Jumping On Vivos Therapeutics, Inc. (NASDAQ:VVOS)
Apr 18Vivos Therapeutics again delays Q2 2022 results
Aug 23Vivos Therapeutics signs exclusive distribution agreement with GM Instruments for US and Canada
Jun 29Vivos Therapeutics, Inc. (NASDAQ:VVOS) Analysts Are More Bearish Than They Used To Be
May 21Vivos Therapeutics: First Take After The Broad Market Sell-Off
Mar 06Vivos Therapeutics: Reimagining Sleep
Jul 30Vivos Therapeutics prices $24M follow-on offering
May 07Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 22 | -6 | N/A | -7 | 2 |
| 12/31/2024 | 16 | -10 | N/A | -10 | 2 |
| 6/30/2024 | 14 | -12 | -12 | -11 | N/A |
| 3/31/2024 | 13 | -16 | -12 | -11 | N/A |
| 12/31/2023 | 14 | -14 | -13 | -12 | N/A |
| 9/30/2023 | 15 | -15 | -13 | -12 | N/A |
| 6/30/2023 | 15 | -19 | -16 | -15 | N/A |
| 3/31/2023 | 16 | -20 | -18 | -17 | N/A |
| 12/31/2022 | 16 | -24 | -21 | -20 | N/A |
| 9/30/2022 | 16 | -25 | -22 | -21 | N/A |
| 6/30/2022 | 17 | -25 | -20 | -19 | N/A |
| 3/31/2022 | 17 | -22 | -20 | -18 | N/A |
| 12/31/2021 | 17 | -20 | -18 | -16 | N/A |
| 9/30/2021 | 16 | -24 | -17 | -15 | N/A |
| 6/30/2021 | 15 | -21 | -14 | -12 | N/A |
| 3/31/2021 | 13 | -19 | -9 | -9 | N/A |
| 12/31/2020 | 13 | -18 | -6 | -6 | N/A |
| 9/30/2020 | 13 | -9 | -4 | -4 | N/A |
| 6/30/2020 | 13 | -11 | -4 | -4 | N/A |
| 3/31/2020 | 12 | -12 | -4 | -4 | N/A |
| 12/31/2019 | 11 | -12 | -6 | -5 | N/A |
| 12/31/2018 | 4 | -9 | -7 | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VVOS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VVOS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VVOS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VVOS's revenue (29.7% per year) is forecast to grow faster than the US market (8.6% per year).
High Growth Revenue: VVOS's revenue (29.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VVOS's Return on Equity is forecast to be high in 3 years time